# Ashwagandha Sleep Quality Randomized Trial: What the Evidence Says
Canonical: https://www.migaku.app/guides/ashwagandha-sleep-quality-randomized-trial-evidence-review
Category: evidence-review
Summary: Ashwagandha Sleep Quality Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass 
Last reviewed: 2026-07-06
Reviewed by: Migaku Evidence Review
# Ashwagandha Sleep Quality Randomized Trial: What the Evidence Says

## Quick Answer

Ashwagandha Sleep Quality Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 2 randomized trial.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Comparative Evaluation of Ashwagandha ( Withania somnifera ) Root Extract and Melatonin for Improving Sleep Quality in Adults: A Prospective, Randomized, Double-Blind, Placebo-Controlled Study | randomized trial | 2 | 2026-03-27 | 10.3390/clockssleep8020015 |
| Efficacy and safety of Ashwagandha root extract sustained-release (AshwaSR) capsules in healthy adult, stressed subjects: A randomized, double-blind, placebo-controlled, parallel-group, 3-arm clinical trial | randomized trial | 2 | 2026-03-13 | 10.1097/MD.0000000000047990 |

## What The Sources Report

- Sleep disturbances also carry broader social and economic consequences, such as more missed workdays, reduced productivity, increased healthcare use, and a higher risk of workplace or traffic accidents. [Movva Navya (2026); evidence level 2]
- Epidemiological data show that the prevalence of sleep disturbance rises with age and is impacted by characteristics including female gender, reduced socioeconomic status, and concomitant medical conditions. [Movva Navya (2026); evidence level 2]
- There is a paucity of evidence assessing the efficacy and safety of low-dose formulations of Ashwagandha in stress management. [Thanawala Shefali (2026); evidence level 2]
- We evaluated the efficacy and safety of AshwaSR capsules at doses of 150 and 300 mg in reducing stress and associated symptoms in healthy adults experiencing stress, over a period of 60 days of administration. [Thanawala Shefali (2026); evidence level 2]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For ashwagandha sleep quality randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Movva Navya (2026). Comparative Evaluation of Ashwagandha ( Withania somnifera ) Root Extract and Melatonin for Improving Sleep Quality in Adults: A Prospective, Randomized, Double-Blind, Placebo-Controlled Study. DOI: 10.3390/clockssleep8020015. PMCID: PMC13108063. PMID: 42029558. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13108063/
- Thanawala Shefali (2026). Efficacy and safety of Ashwagandha root extract sustained-release (AshwaSR) capsules in healthy adult, stressed subjects: A randomized, double-blind, placebo-controlled, parallel-group, 3-arm clinical trial. DOI: 10.1097/MD.0000000000047990. PMCID: PMC12991725. PMID: 41824889. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12991725/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.